Symbol: |
ELOVL1
|
Description: |
ELOVL fatty acid elongase 1 [Source:HGNC Symbol;Acc:14418]
|
Location: |
Chr1:43829068-43833697[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:538
Gene |
Compound |
Gen_sig |
Exp_pattern |
ELOVL1 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.022 |
Up |
ELOVL1 |
6-(3-Aminopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo- 3-nitro-11H-indeno[1,2-c]isoquinoline Hydrochloride Salt |
0.023 |
Up |
ELOVL1 |
Dasatinib |
0.002 |
Down |
ELOVL1 |
NSC 733155 |
0.021 |
Up |
ELOVL1 |
NSC 734385 |
0.006 |
Up |
ELOVL1 |
NSC 734631 |
0.001 |
Up |
ELOVL1 |
6-(3-Azido-propyl)-2,3-dimethoxthy-5,11-dioxo-5,11-dihydro-6 H-indeno[1,2-c]isoquinoline-9-carbonitrile |
0.048 |
Down |
ELOVL1 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.016 |
Down |
ELOVL1 |
NSC 736021 |
0.01 |
Down |
ELOVL1 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.006 |
Up |
ELOVL1 |
4-[(Z)-2-phenylethenyl]-6-(3,5,5-trimethyl-4,5-dihydro-1H-py razol-1-yl)-1,3,5-triazin-2-ylamine |
0.039 |
Up |
ELOVL1 |
2-(4-chloro-2-methylphenoxy)-N-(4-chlorobenzo[d]thiazol-2-yl )acetamide |
0.036 |
Up |
ELOVL1 |
6-(10'-tert-BOC-aminododecyl)-5,6-dihydro-5,11-dioxo-11H-indeno-[1,2-c]isoquinoline |
0.023 |
Down |
ELOVL1 |
1,4-Dimethyl-14-oxa-3-dioxothia-tetracyclo[9.2.1.0.0]tetradeca-4,6,8,12-tetraene |
0.011 |
Up |
ELOVL1 |
6-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one |
0.001 |
Up |
Expression pattern: Sensitivity / Resistance
Total:36 Current:34
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:38
Total:3 Current:1
[First] [Prev]  Next Last 
|